AOD-9604 Metabolism and Detection: Scientific Overview
RESEARCH AOD-9604 Metabolism and Detection: Scientific Overview Scientific literature regarding AOD-9604 metabolism studies indicates that this modified C-terminal fragment of human growth hormone undergoes rapid enzymatic degradation when exposed to human plasma. Analytical frameworks for AOD-9604 peptide detection in a laboratory setting rely on liquid chromatography-mass spectrometry to differentiate the peptide from its parent hormone and subsequent metabolites [1]. Compound identity: CAS 221231-10-3 · C78H123N23O23S2 · 1815.1 g/mol (verified via PubChem)
The Structural Basis of AOD-9604
AOD-9604 is a synthetic peptide representing the C-terminal fragment of human growth hormone (hGH), specifically encompassing amino acids 177-191 with an added tyrosine residue at the N-terminus to facilitate structural stability [1]. By isolating this specific sequence, researchers aim to study the metabolic pathways of the fragment independently of the full-length protein. Because the peptide is a truncated derivative, its behavior in biological matrices differs significantly from the endogenous hormone, necessitating precise analytical methods to track its stability and transformation [1].
Insights from AOD-9604 Metabolism Studies
In vitro metabolism studies provide the primary evidence for how this peptide behaves in a physiological environment. When incubated in human plasma, AOD-9604 does not remain intact for extended durations; rather, it is subject to rapid proteolytic cleavage [1]. Research indicates that the peptide is susceptible to degradation by plasma enzymes, which break the chain into smaller, secondary fragments [1]. These in vitro findings are critical for researchers because they establish that the peptide has a relatively short half-life in a blood-simulated environment, a factor that dictates the parameters for any subsequent analytical observation [1].
Analytical Challenges in AOD-9604 Peptide Detection
The detection of AOD-9604 in laboratory samples presents a distinct challenge due to its structural similarity to the C-terminus of hGH. Because the peptide is essentially a fragment of a naturally occurring hormone, identifying it requires highly sensitive instrumentation, such as liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) [1]. This technique allows researchers to isolate the specific mass-to-charge ratio of the peptide, distinguishing it from the background noise of other plasma proteins and metabolic byproducts [1]. The methodology focuses on identifying the specific molecular weight and fragmentation pattern unique to the modified 177-191 sequence [1].
Understanding AOD-9604 Pharmacokinetics
While the term AOD-9604 pharmacokinetics is often discussed, current literature is primarily limited to in vitro degradation profiles rather than comprehensive human clinical pharmacokinetic modeling. The existing data confirms that the peptide is rapidly metabolized in human plasma in vitro, which suggests that its stability in a physiological environment is limited by these enzymatic processes [1]. Researchers have not yet fully mapped the complete metabolic clearance pathway in vivo, leaving the precise kinetics of secondary metabolite excretion as an area requiring further investigation [1].
Limitations of Current Research
It is important to distinguish between what has been observed in vitro and what remains unknown. The current body of research does not provide a complete map of the peptide’s long-term stability in diverse tissue types, nor does it offer data on the physiological impact of the various metabolites produced during the degradation process [1]. Furthermore, the interaction between this peptide and specific cellular receptors has not been fully characterized in the context of its rapid metabolic breakdown [1]. To ensure the integrity of research, scientists must verify the identity and purity of materials through rigorous analytical documentation [1].
Frequently asked questions
How is AOD-9604 metabolism studied in a laboratory? Metabolism is studied using in vitro incubation methods where the peptide is introduced into human plasma samples. Researchers then use liquid chromatography-mass spectrometry to monitor the rate at which the peptide is cleaved by plasma enzymes over time [1]. What does the evidence say about AOD-9604 stability? The evidence indicates that AOD-9604 is not stable in human plasma and undergoes rapid degradation into smaller fragments [1]. This instability is a fundamental characteristic observed in in vitro studies [1]. Can AOD-9604 be distinguished from human growth hormone? Yes, analytical techniques like LC-MS/MS are capable of distinguishing the specific 177-191 fragment from the full-length human growth hormone molecule by identifying unique mass-to-charge ratios and specific fragmentation patterns [1]. Are there human clinical trials on AOD-9604 pharmacokinetics? The available scientific literature focuses on in vitro metabolism and detection methods [1]. Comprehensive human pharmacokinetic studies are not currently defined within the scope of the provided research [1]. What is the role of the tyrosine residue in AOD-9604? The tyrosine residue is added to the N-terminus of the 177-191 fragment to assist in structural stability and to facilitate analytical detection during research procedures [1]. To ensure the integrity of research, scientists must verify the identity and purity of materials through rigorous analytical documentation. This process involves examining the Certificate of Analysis (COA) to confirm that the peptide sequence matches the intended structure and that the purity levels meet the requirements for the specific experimental model. Lot tracking is essential, as it allows researchers to maintain a clear chain of custody from the initial synthesis through to the final analytical verification, ensuring that the material used in any study is consistent and accurately identified. Research use only. The compounds discussed are supplied for laboratory research and are not for human or veterinary use. Nothing on this page is medical advice, a dosing guide, or a claim about any product sold here; it summarises published research and cites its sources.
References
Authoritative sources cited for research context. Research use only — not medical advice.
